SCHEMBL19078931

SCHEMBL19078931

COC[C@H]1O[C@@H](C)[C@H](F)C1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17124623 1.00 — —
SCHEMBL17775028 1.00 — —
SCHEMBL17124624 1.00 — —
SCHEMBL12769067 1.00 — —
SCHEMBL767704 0.84 — —
SCHEMBL20419054 0.82 — —
SCHEMBL18294595 0.81 FGF1 (0.33) —
SCHEMBL19051014 0.81 FGF1 (0.33) —
SCHEMBL25605193 0.81 FGF1 (0.33) —
SCHEMBL25594520 0.81 FGF1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174989-A1 Methods and Compositions for the ADAR-Mediated Editing of ABCA4 KORRO BIO, INC. (US) 2023-06-08 — — US disclosed
US-20170283496-A1 OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION HOFFMANN-LA ROCHE INC. 2017-10-05 — — US disclosed
US-20170191064-A1 OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2017-07-06 — — US disclosed
Send feedback